Press releases in 2001

24. 12. 2001 |
Ljubljana, December 24 – The Slovenian pharmaceutical company Lek announces that it has received tentative approval from US regulatory authorities to market the anti-hypertensive product lisinopril in the U.S. market ...
17. 12. 2001 |
Kranjska Gora, December 17 – Today, a few days ahead of schedule, we officially opened the renovated lodging and recreational facilities of Hotel Lek in Kranjska Gora. The Slovenian pharmaceutical ...
7. 12. 2001 |
Warsaw, Ljubljana, December 7 – Lek Polska celebrates its tenth birthday in December. In the first eleven months of 2001, its sales reached EUR 50 million, representing 1.77 percent of ...
3. 12. 2001 |
Ljubljana, December 3 – The pharmaceutical company Lek’s newspaper has been recognized as the most enterprising internal newspaper in Slovenia by the Slovenian marketing and communication magazine Splet. According to ...
30. 11. 2001 |
Ljubljana, November 30 – The pharmaceutical company Lek today introduces its new image on the World Wide Web. The primary goal of the web masters who created, designed and service ...
29. 11. 2001 |
Ljubljana, November 29 – Today the Slovenian Minister of Economics, Tea Petrin, the Minister of Education, Science and Sport, Dr. Lucija Cok and the representatives of Lek held a meeting ...
15. 11. 2001 |
Prevalje, 15 November – In its penicillin production plant at Prevalje, the pharmaceutical company Lek d.d. presented its environmental policy implementation at that location.
14. 11. 2001 |
Ljubljana, November 14 – Sales of the pharmaceutical company Lek d.d. (Lek) in the first nine months of this year totalled SIT 50.4 billion, which is a 24.4% growth compared ...
23. 10. 2001 |
Beijing, Ljubljana, October 23, 2001- The Slovene minister of Health, Prof. Dr. Dušan Keber, together with Lek’s president of the Board of Management, Metod Dragonja, officially opened Lek’s new representative ...
11. 10. 2001 |
Ljubljana, 11 October 2001 – Lek’s Board of Management, with the approval of the Supervisory Board, adopted all the necessary measures to complete the reorganisation of the Cosmetics business segment, ...
9. 10. 2001 |
Ljubljana, 9 October 2001 – Slovenian based pharmaceutical company Lek d.d. (Lek), and Sofotec GmbH & Co. KG (Sofotec), the German pharmaceutical company focussing on inhale technologies, signed a contract ...
28. 9. 2001 |
Bucharest, September 28th – Lek announced that its take-over of the Romanian company PharmaTech proceeds as scheduled. Lek PharmaTech ranks fifth on the Romanian pharmaceutical market. The company’s growth of ...
20. 8. 2001 |
Lendava, 20 August 2001 – On 20 August, the Lendava Municipality Day, a solemn opening of the Lendava Wastewater Treatment Plant built through joint efforts of Lek Pharmaceutical Company and ...
3. 8. 2001 |
Ljubljana, August 3, 2001 – The international pharmaceutical company Lek d.d. (Lek) has modified its strategy with respect to the US market. In addition to continuing its activities as a ...
18. 7. 2001 |
Ljubljana, July 18th – Minor or major medical problems ranging from allergies and insect bites to dehydration and the like, often ruin our vacations.  Proper preparation before leaving on a ...
12. 7. 2001 |
Ljubljana, 12 July – In the first half-year of 2001 the Slovenian pharmaceutical company Lek d.d. (Lek) had sales of SIT 34.5 billion which is a 26% growth compared to ...
10. 7. 2001 |
Ljubljana, 10 July – The Friends of the Youth Association of Slovenia is a non-governmental, voluntary, humanitarian and non-profit organization whose basic aim is to raise the quality of life ...
5. 7. 2001 |
Ljubljana, July 5th – The International ISO 14001 Certificate specifies the requirements of an environmental management system. The Slovenian Institute of Quality and Metrology certified Lek’s environmental protection system. The ...
3. 7. 2001 |
Ljubljana, July 3rd – The Fourteenth Shareholders’ Meeting convened today at the Lek d.d. headquarters. Shareholders attending the meeting represented 58.42% of the total issued share capital. The majority of ...
26. 6. 2001 |
Ljubljana, June 26th – The international pharmaceutical company Lek d.d. (Lek) received approval of its Amoksiklav manufacturing facilities in Prevalje from the British Medical Control Agency. The MCA inspection, which ...
22. 6. 2001 |
Lipovci, June 22nd – The international pharmaceutical company Lek d.d. (Lek) sells its products in over 80 world markets. In 20 of these, Lek also markets its line of animal ...
30. 5. 2001 |
Ljubljana, May 30 -The pharmaceutical company Lek d. d. (Lek) today signed a contract with IBM Slovenija d. o. o., which will provide Lek with the integrated business information system ...
24. 5. 2001 |
Ljubljana, May 24 – At today’s meeting, the Supervisory Board of Lek d.d. (Lek) discussed the agenda for the Fourteenth Annual Meeting of Shareholders. It was decided that the annual ...
23. 5. 2001 |
Kranjska Gora, May 23 – At a press conference today, the representatives of Hotel Lek in Kranjska Gora unveiled their investment plan for the hotel. They wish to improve the ...
19. 4. 2001 |
Ljubljana, April 19 – The Slovenian pharmaceutical company Lek d.d. (Lek) today made a presentation at the Ljubljana Pediatric Clinic of two million tolars to Docent Dr. Vasilija Maček, head ...
16. 2. 2001 |
Ljubljana, February 16, 2001 – Lek d.d. (Lek) the Slovenian pharmaceutical company announces signing a contract to acquire an 89.45% share of the Polish pharmaceutical company Argon SA (Argon). This ...
26. 1. 2001 |
Ljubljana, 26 January – In the year 2000 the Slovene pharmaceutical company Lek exceeded its sales objectives. In this period Lek had sales of 54.9 billion SIT, hereby achieving 18% ...
10. 1. 2001 |
Ljubljana, Bucharest, January 10 – The Slovenian pharmaceutical company Lek, is announcing the purchase of a 90% stake in the privately-held Romanian pharmaceutical company, PharmaTech. The two companies see a ...
8. 1. 2001 |
Ljubljana, January 8 – Today the thirteenth General Meeting of Lek d.d. took place at the Slovenian pharmaceutical company Lek, Ljubljana. At the beginning of the meeting, 43.56% of the ...